Vaccine makers need to take into account genetic diversity explicitly in clinical trials or risk missing coverage for some individuals, says MIT scientists.
Read more at ZDNet…
Vaccine makers need to take into account genetic diversity explicitly in clinical trials or risk missing coverage for some individuals, says MIT scientists.
Read more at ZDNet…